Financials
Financial year 2025
Fund+ from Leuven, company number BE0629896521, closed financial year 2025 with a result of € -1.8 million after tax. For that financial year Fund+ recorded a gross margin of € -1.3 million and equity of € 124 million. Compared with financial year 2024, the result moved from € 2.3 million to € -1.8 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.
€ 124 million
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.8 million
▼ still € 2.3 million profit in 2024
Profit after tax over the fiscal year.
€ 4.2 million
▼ 50% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 17.1 million.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 260,072
▲ 34% vs 2024
€ 260,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 6,475
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 20,257
▼ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,561
▲ 18% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 1,695 | - | |
| Gross margin | € -2,315,201 | € -2,735,814 | € -1,927,170 | € -1,313,569 | ▲ € 613,601 |
| Profit after taxes | € -4,280,052 | € 17,178,847 | € 2,289,239 | € -1,768,019 | ▼ € 4.1 million |
| Equity | € 119,593,001 | € 118,985,756 | € 121,274,995 | € 124,005,976 | ▲ 2% |
| Total debts | € 245,208 | € 24,541,612 | € 1,736,272 | € 98,832 | ▼ 94% |
| Cash | € 678,459 | € 1,645,536 | € 8,258,827 | € 4,158,157 | ▼ 50% |
| Retained profit | € 17,153,383 | € 16,546,138 | € 18,835,377 | € 17,067,358 | ▼ 9% |
| Dividend | € 0 | € 17,786,093 | € 0 | € 0 | |
| Bank debt | € 0 | € 5,500,000 | € 0 | € 0 | |
| Balance sheet total | € 119,838,209 | € 143,527,368 | € 123,011,267 | € 124,104,807 | ▲ 1% |
| Employees (FTE) | 1.3 | 1.7 | 1 | 1 |
Key figures of Fund+, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Fund+?
What happened at Fund+ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Luc Debruyne stepped down as director. NBB
- Chris Buyse stepped down as director. NBB
- François Fontaine stepped down as director. NBB
- LGP Advisory BV stepped down as director. NBB
- Dr. Ir. U. Vandeurzen Management Firm NV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.8 million (▼ € 4.1 million vs 2024). Source: NBB ↗
- Chris Buyse became a director. NBB
- Luc Debruyne became a director. NBB
In short
From € 4.3 million loss in 2022 to € 1.8 million loss in 2025.
Paid € 5,924 in corporate taxes since 2022.
Best year ever: 2023, with € 17.2 million profit.
Paid out € 17.8 million in dividends to the owners in total.
A new publication or filing at Fund+? We notify you, reason included.
Follow Fund+Databakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, VF Capital, MULTIFIN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Fund+The shares are held by SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (19.5%), VF Capital (13.1%) and MULTIFIN (12.3%). It owns 31.2% of ETHERNA IMMUNOTHERAPIES, 22.8% of Confo Therapeutics, 20.2% of Octimet Oncology NV, 20.1% of Novadip Biosciences, 19.9% of Aelin Therapeutics NV and 19.6% of Ona Therapeutics itself.
Directors
According to the 2025 annual accounts
since 2024 · until 2028
Chris Buyse
Director
Also active at: Life Sciences Research Partners, CoBioRes, Bio-Incubator Leuven
since 2024 · until 2028
François Fontaine
Director
since 2020 · until 2028
Director
since 2024 · until 2028
Dr. Ir. U. Vandeurzen Management Firm NV
Director · represented by Urbanus (roepnaam Urbain) Vandeurzen
Owns 13.1% via VF Capital
Also active at: DI LEGNO INTERIORS, DLI Invest, ALDEA CONSTRUCT, miDiagnostics, HARMONEY, Smile Invest, Smile Invest Management Company, Triginta +5 more
since 2020 · until 2028
Shareholders
VF Capital · holding of Dr. Ir. U. Vandeurzen Management Firm NV
13.1%
12.3%
Participations
31.2%
22.8%
20.2%
20.1%
19.9%
Ona Therapeutics
19.6%
19%
17.2%
15.3%
15%
Targed Biopharmaceuticals
14.2%
12.6%
Coave SAS
10.6%
Minoryx Therapeutics SL
9.2%
Tubilis GMBH
7.5%
6.3%
3.1%
0.9%
Establishments
Establishment units
Physical locations of this company
Groot Begijnhof 60 box 1
3000 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0629.896.521
- VAT number
- BE 0629.896.521
- Registered office
- Groot Begijnhof 60 bus 1, 3000 Leuven
- Names & denominations
- Fund+
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 May 2015
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Activiteiten van geldmarkt- en niet-geldmarktbeleggingsfondsen
Beleggingstrusts en -fondsen en vergelijkbare financiële instellingen